Eingeschlossene Patienten: 23.308 (Stand 03. Februar 2025)
Amgevita® (Adalimumab)
244
Benepali® (Etanercept)
1247
Cimzia® (Certolizumab)
1044
Enbrel® (Etanercept)
2877
Erelzi® (Etanercept)
581
Flixabi® (Infliximab)
10
Hukyndra® (Adalimumab)
10
Hulio® (Adalimumab)
276
Humira® (Adalimumab)
2911
Hyrimoz® (Adalimumab)
252
Idacio® (Adalimumab)
68
Imraldi® (Adalimumab)
237
Inflectra™ (Infliximab)
16
Jyseleca® (Filgotinib)
163
Kevzara® (Sarilumab)
227
Kineret® (Anakinra)
89
MabThera® (Rituximab)
1459
Nepexto® (Etanercept)
96
Olumiant® (Baricitinib)
550
Orencia® (Abatacept)
994
Remicade® (Infliximab)
762
Remsima® (Infliximab)
27
Rinvoq® (Upadacitinib)
321
Rixathon® (Rituximab)
20
RoActemra® (Tocilizumab)
1379
Ruxience® (Rituximab)
1
Simponi® (Golimumab)
476
Truxima® (Rituximab)
3
Tyenne® (Tocilizumab)
50
Xeljanz® (Tofacitinib)
400
Yuflyma® (Adalimumab)
50
Zessly® (Infliximab)
2
Kontrollen
6466
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok